Anaerobic infections (third of three parts).
D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D001431:Bacteriological Techniques; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D018805:Sepsis / Q000453:epidemiology; D013923:Thromboembolism / Q000209:etiology; D014946:Wound Infection
D000900:Anti-Bacterial Agents